-
Cutting-edge genomic technology to help improve medication safety for children in new BC Children’s led study
For the past 20 years, the Canadian Pharmacogenomics Network for Drug Safety (CPNDS) has been working to identify why patients have different responses to drug treatments. As part of a recent $200 million Genome Canada initiative, Dr. Bruce Carleton will be leading a new $17 million project to expand on the work of the CPNDS to make medications safer for…
-
Digestive ‘treasure chest’ shows promise for targeted drug treatment in the gut
A new approach to drug design can deliver medicine directly to the gut in mice at significantly lower doses than current inflammatory bowel disease treatments.
-
BCCHR researchers develop new way to match young cancer patients with the right drugs
A pan-Canadian team has developed a new way to quickly find personalized treatments for young cancer patients, by growing their tumours in chicken eggs and analyzing their proteins.
